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Background: Arsenic in drinking water causes increased coronary artery disease (CAD) and death from CAD, but its
association with stroke is not known.
Methods: Prospective cohort study with arsenic exposure measured in well water at baseline. 61074 men and
women aged 18 years or older on January 2003 were enrolled in 2003. The cohort was actively followed for an
average of 7 years (421,754 person-years) through December 2010. Based on arsenic concentration the population
was categorized in three groups and stroke mortality HR was compared to the referent. The risk of stroke mortality
Hazard Ratio (HR) and 95% Confidence Interval was calculated in relation to arsenic exposure was estimated by Cox
proportional hazard models with adjustment for potential confounders.
Results: A total of 1033 people died from stroke during the follow-up period, accounting for 23% of the total deaths.
Multivariable adjusted HRs (95% confidence interval) for stroke for well water arsenic concentrations <10, 10-49, and ≥50
μg/L were 1.0 (reference), 1.20 (0.92 to 1.57), and 1.35 (1.04 to 1.75) respectively (Ptrend=0.00058). For men, multivariable
adjusted HRs (95%) for well water arsenic concentrations <10, 10-49, and ≥50 μg/L were 1.0 (reference), 1.12 (0.78 to 1.60),
and 1.07 (0.75 to 1.51) respectively (Ptrend=0.45) and for women 1.0 (reference),1.31 (0.87 to 1.98), and 1.72 (1.15 to 2.57)
respectively (Ptrend=0.00004).
Conclusion: The result suggests that arsenic exposure was associated with increased stroke mortality risk in this
population, and was more significant in women compared to men.Background
An estimated 100 million people worldwide are currently
exposed to elevated concentrations of arsenic in their
drinking water [1]. Internal cancers (lung, bladder, kidney
and liver) and numerous non-cancer diseases are associ-
ated with elevated levels of arsenic in drinking water [2].
Arsenic contamination in drinking water is an emerging
public health issue globally, particularly in Bangladesh,
where the problem has been called the “greatest mass poi-
soning in history” [3].* Correspondence: mahfuzar@icddrb.org
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reproduction in any medium, provided the orMany studies supports the fact that arsenic in drinking
water causes increased coronary artery disease (CAD) and
death from CAD, but the evidence concerning cerebrovas-
cular disease (stroke mortality) is not conclusive. Stroke
mortality is one of the causes of death, is responsible for
10% of deaths globally [4]. Only a few studies have examined
the impact of arsenic exposure on stroke [5-7]. Environmen-
tal arsenic exposure causes excess stroke mortality among
black foot disease (BFD) patients and residents of Taiwan
[5-7]. BFD means peripheral atherosclerosis resulting in dry
gangrene and spontaneous amputation of affected extrem-
ities and the disease was named for its most striking clinical
feature—blackish discoloration of the feet or hands. Occu-
pational arsenic exposure has also been implicated to stroke
mortality [8]. However, most population based studies were
either ecological or occupational cohort studies. Ecologic
correlation studies may have the problem of ecologicall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Study flow chart. The cohort comprised all inhabitants in
Matlab, Bangladesh, age≥18 years on January 1, 2003, living in the
study area for at least 3 years (reducing loss-to-follow-up); and primary
users of the tested well, with follow-up to death or December 31, 2010
(closed cohort).
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of multiple exposures. Thus, only limited conclusions can
be drawn from these studies.
Given that a high proportion of stroke events result in
death, even a small increase in risk associated with ar-
senic exposure can mean a large number of excess
deaths in the exposed population. In our earlier study,
we reported increased risk of adult cardiovascular mor-
tality in Bangladesh associated with arsenic exposure [9].
However, a limitation of that study was that it lacked in-
dividual exposure data and used household level expos-
ure for the subjects. The Arsenic exposure and health
consequences in Matlab (As Mat) study [10] includes
participants exposed to a wide range of arsenic concen-
trations in drinking water at baseline (0.5 to 3644 μg/L),
using individual level exposure provides a unique oppor-
tunity to investigate the cerebrovascular effects of expos-
ure to arsenic at low-to-moderate concentrations. By
following up this existing cohort we assess the risk of
stroke mortality overall as well as by gender and subtype
of stroke.
Methods
Study area and design
Matlab is a typical rural area of Bangladesh located 55
kilometres southeast of the capital, Dhaka. Matlab is an
area severely affected by arsenic contamination of the
drinking water, with numerous established adverse health
consequences [9,10]. All individuals gave written informed
consent to participate. An icddrb (International Centre for
Diarrhoeal disease Research Bangladesh) institutional re-
view committee and the icddrb Ethical Review Committee
approved the baseline study. A mitigation program was
initiated in collaboration with Bangladesh Rural Advance-
ment Committee (BRAC), Bangladesh.
We assembled our present study cohort, the Arsenic
Adult Cohort (AAC) from our baseline study which con-
sisted of screening and obtaining the lifetime drinking
water history of 166,934 individuals (74,408 male, 92,526
female). Detail of study location describe elsewhere [11].
From population database 220, 000, our primary screen-
ing in 2002-2003 included all individuals greater than 4
years of age were included. Individuals were excluded
who were not living and drinking water of a source in
Matlab at least once per week. A total of 180, 811 indi-
viduals were eligible (Figure 1) and visited their homes
during the study period (January 2002-August 2003).
Thus, 166, 934 individuals (92% of eligible) were inter-
viewed and examined. For this cohort, we recruited
61,074 adults who met our eligibility criteria: age≥18 years
on January 1, 2003, living in the study area for at least 3
years (reducing loss-to-follow-up); and primary users of the
tested well (n=13,286). Participants were followed from
January 01, 2003 until December 31, 2010. Information ondemographic and socio-economic information was collected
at baseline. Community health research workers visit every
household on a monthly basis to update information on
demographic events, i.e. marriages, births, deaths, in- and
out-migrations, as well as to collect information on morbid-
ity of children below 5 years of age and of women of child-
bearing age. Socio-economic information is also recorded
by periodic censuses.
Demographic information were collected monthly basis
and socioeconomic information collected for every 5 years.
We used SES for 2005. This study used prospectively col-
lected health and demographic data collected monthly
through the “Health and Demographic Surveillance System
(HDSS)” during the period from January 2003 to December
2010 collected through verbal autopsy (VA) [12]. Verbal aut-
opsy procedures are widely used for estimating cause spe-
cific mortality in areas where there is no medical record or
formal medical attention given.
Follow-up time in person-years was calculated as the
number of days between the baseline interview to date
of death, out migration date or the end of the study
period (December 31, 2010), whichever came first. Par-
ticipants with an accident-related cause of death such as
road traffic accident, drowning or other accidental
deaths or died from a cause other than stroke or alive
were censored.
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Our outcome of interest was death (18 years and above)
from stroke (International classification of diseases, 10th
revision codes, I61-I69) between January 1, 2003 and
December 31, 2010. Causes of deaths including stroke
were recorded based on routine VA conducted by spe-
cially trained field staff of HDSS who were unaware of
the well water arsenic concentration. After appropriate
training, these field staff interviewed close relatives of
the deceased using a structured verbal-autopsy question-
naire that captures signs and symptoms of diseases/con-
ditions that were present prior to death and medical
consultations that occurred before death. Later, two phy-
sicians independently assigned the underlying causes of
deaths. If there was a disagreement, a third physician re-
solved cause of deaths [12]. They coded the causes by
use of the World Health Organization (WHO) tenth re-
vision of the International Classification of Diseases
(ICD-10). Assignment of causes of death was done in ac-
cordance with the verbal autopsy standards that have
been developed by the INDEPTH network and the
WHO [12]. VA is a well-known instrument for ascer-
taining the cause of death based on information
obtained from close relatives through systematic retro-
spective questioning [12]. Stroke deaths included: Intrace-
rebral hemorrhage, ICD code I61=2; other non-traumatic
hemorrhage, ICD code I62=1; cerebral infarction, ICD
code I63=9; Stroke, ICD code I64=480; ICD code I67=6;
other cerebrovascular diseases, and Sequelae of cerebro-
vascular disease, ICD code I69=535 deaths.
Arsenic exposure assessment
At baseline, 13, 286 tube-wells were functional and tested
for arsenic content. The field teams interviewed all indi-
viduals regarding their water-consumption history, and re-
corded the water sources used, including location, during
each calendar year. Water samples were collected in two
20 ml polyethylene vials. The vials contained acid to pre-
vent precipitation. They were kept at –20°C until analysis.
The concentrations of arsenic were determined in duplicate
by hydride generation atomic absorption spectrophotom-
eter (HG-AAS, Shimadzu Model AA-6800) at Dhaka icddr,
b laboratory. The limit of detection (LOD) was 1 μg/L. In
the calculations, results below LOD were assigned a value
of 0.5 μg/L. Analytical performance was controlled by
analysis of standard reference material, internal water
quality control samples, and inter-laboratory comparison
(Karolinska Institutet). Details of study methodology and
results are given elsewhere [10].
Other study variables
Other covariates were derived from HDSS data. In our
earlier study, increased risks for death were observed
with socioeconomic conditions and education [9]. Assetscores were used based on a household level socioeco-
nomic census in 2005 that contained household-level in-
formation. Using available information for each household
a score was then generated through principal component
analysis. SES scores were first developed for each house-
hold in the study sample. To create the categorical vari-
able, SES scores were sorted from lowest to highest and
divided into equal quintile; higher quartiles reflect higher
SES. Ultimately, we chose to include SES as categorical
variable. All the scores were categorized into five groups
ranging from the lowest (poorest) to highest (richest).
Those with missing SES information (N=867) were im-
puted by the series mean. A sensitivity analysis was used
to examine if the relationship differed when imputed SES
was included in the analysis. Our sensitivity analysis re-
vealed that the outcome remained stable after including
the imputed value of missing SES. Other socioeconomic
and demographic factors included age at baseline (years),
sex and years of education.
Statistical analysis
Baseline age, gender, asset score, education and baseline
arsenic exposure were compared between baseline co-
hort member and deaths, and between participating and
loss to- follow participants, supported by Chi square
testing. The mortality risks in relation to arsenic expos-
ure were estimated by Cox proportional hazards models,
adjusting for potential confounders, and adjusted Hazard
Ratios (HRs) were calculated along with 95% confidence
intervals (95% CI). First we assessed crude association
and then adjusted for covariates. A covariate was identi-
fied as a potential confounder if associated with expos-
ure and outcome at p≤0.10 significance level. Potential
confounders that were found to change the effect esti-
mates by 5% or more were included in the adjusted
multivariate models. Baseline exposure was divided into
three groups (<10, 10-49, and ≥50 μg/L) with the lowest
arsenic exposure level used as reference. Adjusting for
sex, SES, education, and baseline age, we plotted cumu-
lative hazard functions for each exposure category. All
analyses were done using SPSS 15·0 (SPSS Inc, Chicago,
Illinois) software.
Results
A total of 61 074 participants met the eligibility criteria
and were included in the cohort. We observed 4 429
total deaths, excluding accidental deaths (n=192), from
an observation of 421 754 person-years. There were
1033 stroke deaths (ICD codes I61 to I69) accounting
for 23% of total mortality and yielding a mortality rate of
244.9 per 100 000 person-years. 10,704 (15.5%) individ-
uals were lost to follow-up during the study period,
however relatives reported being alive. The majority of
those lost to follow up moved-out due to a new job,
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baseline was 37·0±16·3 years and there were no age dif-
ference between gender (men vs. women 37·2±17·2 vs.
36·9±16·3 years). Baseline water samples ranged from 0.5
to 3 644 μg/L and the median well water arsenic
concentration at baseline was 86.8 μg/L (IQR [inter-
quartile range], 20.5-262.0) for individuals who survived
(n=58,179) and 101.3 μg/L (IQR 20.5-263.4 μg/L) for
those who died.
Table 1 shows the distribution of demographic and ex-
posure characteristics for the baseline cohort and for those
who died from stroke. The crude overall rates for death
were higher among men than women (291.5 per 100 000
person-years vs. 212.6 per 100 000 person-years, P<0.01).
There was difference between age distribution, sex, educa-
tion categories by deceased and survivors (P<0.001). The
crude death rate was more than three times higher in the
“no education” group compared with participants with sec-
ondary education level. The crude death rate was more
than double in the “no education” group compared with
participants with primary education level.
Table 2 shows no significant difference in exposure dis-
tribution between included or excluded persons of thisTable 1 Selected characteristics of participants in relation to
and SES
Variables Baseline arsenic in well water Baseline cohort, N=61,0
Mean SD n %
Age
18-30 164.2 182.4 18,927 31.0%
31-60 161.9 180.4 32,963 54.0%
+60 162.9 178.9 9,184 15.0%
Sex
Male 162.1 179.5 25,967 42.5%
Female 163.3 181.8 35,107 57.5%
Education
0 169.8 181.6 23,771 38.9%
1-5 167.5 183.5 18,810 30.8%
+6 149.0 176.3 18,493 30.3%
SES
1 183.2 186.1 9,039 14.8%
2 170.3 181.1 10,741 17.6%
3 167.9 183.6 12,687 20.8%
4 164.5 178.2 13,445 22.0%
5 139.6 174.8 15,162 24.8%
Baseline arsenic exposure
<10 1.7 2.0 5,566 9.1%
10-49 21.1 7.2 22,686 37.1%
+50 102.2 30.5 32,822 53.7%cohort. There are differences in age, sex, and education
levels.
We found an increased risk of cerebrovascular related
mortalities for the higher exposure groups. Participants
exposed to 10-49 μg/L of well water were 1.20 (95% CI:
0.91 to 1.57) times more likely to die from cerebrovascular
disease compared to participants who were exposed to
<10 μg/L) and participants exposed to ≥50 μg/L of well
water were 1.35 (95% CI: 1.03 to 1.75) times more likely to
die from cerebrovascular disease compared to participants
who were exposed to <10 μg/L (Table 3).
For men, multivariable adjusted HRs (95%) for well
water arsenic concentrations <10, 10-49, and ≥50 μg/L
were 1.0 (reference), 1.16 (0.78 to 1.59), and 1.06 (0.75
to 1.51) respectively and for women 1.0 (reference), 1.31
(0.87 to 1.98), and 1.72 (1.15 to 2.57), respectively.
This increased risk of strokemortality was much more
pronounced in women than men. For women, the mortal-
ity rate for cerebrovascular disease was 117.1 per 100 000
person-years in people drinking water containing <10 μg/L
compared with 238.3 per 100 000 person-years in people
drinking with ≥10 μg/L. The test of trend was significant
for women (P=0.00027) but not for men (p=0.99).vital status, age at baseline, sex, education year, exposure




5 .5% 0.04 <0.0001
187 18.1% 0.76
841 81.4% 14.41
503 48.7% 2.92 <0.001
530 51.3% 2.13
639 61.9% 3.7 <0.001
272 26.3% 1.1
122 11.8% 0.7





62 6.0% 1.6 <0.05
375 36.3% 2.4
596 57.7% 2.6
Table 2 Comparison of the distribution of age, sex, years
of education, SES characteristics, and baseline exposure
for the total cohort and those lost to follow up
Characteristics Variables Participated Loss to
follow-up
P value
N % N %
Age
18-30 11911 23.6% 7016 65.5% <0.001
31-60 29775 59.1% 3188 29.8%
+60 8684 17.2% 500 4.7%
Sex
Male 20482 40.7% 5485 51.2% <0.001
Female 29888 59.3% 5219 48.8%
Education
0 21684 43.0% 2087 19.5% <0.001
1-5 15809 31.4% 3001 28.0%
+6 12877 25.6% 5616 52.5%
SES
1 7778 15.4% 1261 11.8% <0.001
2 9221 18.3% 1520 14.2%
3 10236 20.3% 2451 22.9%
4 11047 21.9% 2398 22.4%
5 12088 24.0% 3074 28.7%
Baseline exposure
<10 4516 9.0% 1050 9.8% <0.002
10-49 18622 37.0% 4064 38.0%
+50 57232 54.1% 5590 52.3%
Table 3 Association of baseline exposure with mortality due to













*Crude death rate per 1000 person-years, **HR was adjusted with age, sex, educatio
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1.69 (95% CI: 1.13 to 2.53) times more likely to die from
stroke mortality compared to those who were exposed to
<10 μg/L (Table 3) while risks were not statistically signifi-
cantly increased in men. The overall survival curves by sex
are shown in Figure 2. A significant test for trend was also
observed for overall (Ptrend =0.00058), for men (Ptrend=0.45)
and for women (Ptrend=0.00004).
Discussion
Statement of principle findings
In our study, the risk of strokerelated morality increased
with increasing arsenic exposure. To our knowledge, this
is the first large population based longitudinal study with
individual level arsenic exposure that focused on stroke
mortality in Bangladesh or elsewhere. Our study high-
lights three main risks: i) We observed an increased risk
of overall stroke mortality with increasing arsenic con-
centration in drinking water, with a significant trend test
and risks in the range of 1.03-1.75 for the high arsenic
groups ii) These risks were particularly marked in
women rather than men and iii) These risks were also
particularly marked for outcomes coded as sequelae of
stroke, with increased risks, e.g. 1.64 (95% CI: 1.08-2.53)
even at arsenic concentrations of 10-50 μg/L which are
within the WHO permissible limit.
Potential mechanism
The association between arsenic exposure and death
from stroke is stronger among women than in men.
Folate plays an important role of developing cerebrovas-
cular disease [13]. Hyperhomocysteinemia, a proxy
measure for B vitamins, has been related with low
plasma folate and vitamin B12. Elevated hyperhomocys-
teinemia is an independent risk factor for stroke andcerebrovascular disease for the total sample and by gender
Rate* HR (95% CI) Ptrend
Unadjusted Adjusted**
2.3 1.0 1.0 0.45
3.1 1.37 (0.96- 1.95) 1.12 (0.78- 1.60)
3.6 1.30 (0.92- 1.84) 1.07 (0.75- 1.51)
1.2 1.0 1.0 0.00004
1.9 1.65 (1.09- 2.49) 1.31 (0.87- 1.98)
2.6 2.06 (1.38- 3.07) 1.72 (1.15- 2.57)
1.6 1.0 1.0 0.00058
2.4 1.48 (1.13- 1.93) 1.20 (0.92- 1.57)
3.0 1.62 (1.24- 2.10) 1.35 (1.04- 1.75)
n attainment and SES.
Figure 2 Cumulative survival of cerebrovascular mortality of
women plotted against time for baseline arsenic exposure
categories and adjusted for educational attainment, and SES.
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homocysteine causes atherogenesis and thrombogenesis
via endothelial damage, focal vascular smooth muscle
proliferation probably causing irregular vascular contrac-
tion, and coagulation abnormalities. Oxidative damage
to the vascular endothelium and the proliferation of the
vascular smooth muscle create a prothrombotic condi-
tion, which contributes to the development of premature
atherosclerosis. Moreover, hyperhomocysteinemia has
also been documented risk factor for cardiovascular dis-
ease and vascular dementia [15,16]. Contrary, many epi-
demiologic studies suggest that persons with impaired
arsenic metabolism are at increased risk for diseases and
this metabolism involves methylation to monomethylar-
sonic acid (MMA) and dimethylarsinic acid (DMA) by a
folate-dependent process. Very recently folic acid sup-
plementation causes improvement in arsenic metabolism
[17,18]. Persons possessing polymorphisms in certain
genes involved in folate metabolism excrete a lower pro-
portion of urinary arsenic as DMA, which may influence
susceptibility to arsenic toxicity, suggesting synergistic
affect to increase the risk of stroke. Typically, Bangla-
deshi women are slender and short [19] as well as
anemia and iron deficiencies are also prevalent [20,21].
The potential mechanism by which arsenic may increase
vascular risk is still speculative. Both diabetes and hyper-
tension have been associated with arsenic and are risk fac-
tors for stroke. The most informative studies regarding
diabetes mellitus have been performed in Taiwan, Sweden,
and Bangladesh in arsenic exposed population [22-25].Reports indicate that arsenic induces renal insufficiency
through cortical necrosis with haematuria, leukocyturia,
and glucosuria [26] and that it inhibits the binding capabil-
ity of the glucocorticoid receptor [27]. In addition, arsenic
may damage the endothelial barrier in the vascular system
and also activate leukocytes and platelets and thereby initi-
ate plaque formation [28]. It is already documented that
chronic arsenic exposure causes hypertension [29-34] and
there are many biologically plausible routes for this. Firstly
arsenic may directly accelerate atherosclerosis and increase
production of reactive oxygen, [35] and nitrogen species
[36]. Secondly inhibition of endothelial nitrogen oxide syn-
thesis and enhanced vasoconstriction by arsenic.
Smoking is a well-known risk factor for stroke mortal-
ities. However, we did not collect smoking information
in this study. Razzaque et al found high prevalence of
smoking (53·9% among male, 0·8% among female) in the
adult population in Matlab [37]. In recent Matlab stroke
study revealed no association with smoking (OR 1.41,
95% CI 0.82 to 2.45, P=0.22) [38].
Strength and limitation
Strengths of our study include the large sample size, the
collection of data on individual level baseline arsenic ex-
posure, and the prospectively collected independent out-
come data from the HDSS databases. These include larger
outcome data over an extended follow-up time (over 1033
deaths recorded during more than 0·5 million person-years
at risks). Secondly, standardized approaches to adjustment
for several potential confounding factors, assessment of
risk factors in 61,074 participants and information about
cause-specific deaths from widely validated verbal autopsy
methods contribute to the strength of the study. Selection
and information biases were minimized by combining out-
come data from the regular monthly surveillance at the
household level with exposure data from the cross-
sectional survey of arsenic concentrations in all tube-wells
and interviews about drinking water history at the individ-
ual level. About 46% of the people (N=28,252) had expos-
ure less than 50 μg/L which is larger in size than the total
number of other cohort [HEALS (Health Effects Arsenic
Longitudinal Study)] in Bangladesh [39].
Despite the strengths, several biases could persist own-
ing to unmeasured or imprecisely measured potential
confounding factors (smoking and betel squid history
and blood pressure for example). The major weakness of
the study is that exposure was assessed only once at
baseline. Also, we considered only well water arsenic ex-
posure and did not estimate exposure from other
sources, such as diet. The unaccounted changes of As
sources across the observational time is a weakness. Ar-
senic concentration in the tube-well water, as deter-
mined in 2002–2003, had remained similar during the
follow-up period, we assume. Temporal variations of
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plored. Repeated water analyses were found to be fairly
stable over a 3-year period in Bangladesh [40] and also
in West Bengal [41]. Further, the British Geological Sur-
vey (BGS) analyzed random samples from all over the
country for a 1.5-year period without showing any time
trends [42]. In western Nevada in the United States, and
northern Argentina the water arsenic concentrations
remained about the same over periods of 10–20 years
[43,44]. Moreover, in our study area, when following 61
randomly selected tube wells three times per year over a
3-year period, no systematic time trends could be shown
[45]. Therefore, findings are to be interpreted under the
assumption of constant source of As measured in 2003
and that the impact of possible changes is unknown.
Considering smoking data, smoking is well known risk
factor for stroke mortalities and very few women are re-
ported to smoke in Bangladesh. Women use betal squid
in rural areas and recently suggested is likely contribut-
ing to high blood pressure in Bangladeshi women [46].
Therefore, we separately analysed the data by sex. Thus
we believe there is a true effect of arsenic exposure on
death from stroke and do not believe our study findings
would differ much with adjustment for smoking. To be a
confounding factor for stroke people with high arsenic
specifically smoke more which is unlikely.
Conclusion
In an adult population, a dose-response relationship was
observed between arsenic exposure and stroke mortality in
this population, particularly in women. While arsenic miti-
gation programs are on-going, the resulting health effects
of this catastrophe deserve urgent attention and resources.
Despite limitation, because of uniqueness population-
exposure data at individual level and the independent pro-
spective demographic surveillance system covering 0·2 mil-
lion population for about five decades, future research
from this cohort will further strengthen our knowledge
and help identify effective prevention program.
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